Derma PCD Franchise in Delhi — Clinical Skincare Distributor Opportunity
Exclusive Monopoly Territory Rights Across Delhi NCR — High-Margin Clinical Derma Portfolio Now Accepting Partners
Why Delhi Represents a High-ROI Derma Franchise Territory
Delhi-NCR hosts India's highest concentration of premium dermatology clinics, aesthetic centres, and modern pharmacy chains. With over 4,200 registered dermatologists in the region and a rapidly growing skin-conscious upper-middle class, the clinical skincare market in Delhi represents a multi-crore recurring revenue opportunity for the right franchise partner.
Delhi NCR accounts for approximately 18% of India's total premium dermatology product consumption. Post-inflammatory hyperpigmentation (PIH) and photoageing are the top two dermatological concerns in this high-UV, high-pollution urban zone.
Open Districts in Delhi (NCR)
Territories marked open are available for exclusive franchise allocation. First-confirmed partner takes the territory.
Five WHO-GMP Clinical SKUs Engineered for Indian Skin
Not 200 generic products. A focused, high-velocity clinical range where every SKU has a dermatologist prescription rationale and a defensible active concentration.
Vitamin C 20% Serum
20% Vit C · 2% Niacinamide · Hyaluronic Acid
Indication: Hyperpigmentation · PIH · Dull Skin
Tyrosinase inhibition + melanosome transfer blockade
Hybrid Invisible Sunscreen SPF 50
Physical + Chemical dual-filter system
Indication: Photoprotection · PIH Prevention
Zero white cast on Fitzpatrick III–VI · Sweat resistant
Face Wash
Glycolic Acid · Salicylic Acid · Vitamin C · Cica
Indication: Acne · Oily Skin · Comedonal Acne
AHA + BHA dual exfoliation with anti-inflammatory modulation
Advanced Night Cream
Retinol · Ceramides · Peptides
Indication: Barrier Repair · Anti-Ageing · TEWL Reduction
Collagen synthesis + ceramide barrier restoration
Face & Body Lotion
Vitamin C · Dermawhite™ Technology
Indication: Year-round Hydration · Brightening
Advanced depigmentation technology · 100ml
Pharma-Grade Standards & Direct B2B Economics
National Regulatory Compliance
Every Barekyne formulation complies strictly with the Drugs and Cosmetics Act, 1940. Manufacturing is conducted exclusively in WHO-GMP and ISO 9001:2015 certified facilities to ensure pharmaceutical-grade consistency and safety.
- ✓ CDSCO Approved active ingredient percentages
- ✓ Certified cruelty-free, paraben-free formulations
- ✓ Stabilizer-protected active ingredient delivery systems
Direct-From-Manufacturer Profitability
By bypassing third-party super stockists and traditional distributors, we guarantee direct-from-manufacturer supply lines, enabling industry-leading ROI on B2B skincare procurement.
- ✓ 50% to 58% net margins on high-MRP products
- ✓ Initial franchise packages starting at INR 50,000
- ✓ Continuous scientific visual aid & detailing support
Secure Your Delhi Franchise Territory Today
Once a territory is allocated, it is closed. Exclusive monopoly rights are granted to the first confirmed franchise partner in each district. Fill the form below — our B2B team reviews applications within 48 hours.